SPY311.36-0.82 -0.26%
DIA263.33+0.16 0.06%
IXIC9,615.81-67.10 -0.69%
News
PTI
--
0.00%
--
3 Strong Buy Penny Stocks That Could See Outsized Returns
TipRanks · 16h ago
71 Biggest Movers From Yesterday
Gainers Cemtrex, Inc. (NASDAQ: CETX) shares climbed 172.4% to close at $2.58 on Monday following earlier press release highlighting release of new thermal body temperature measurement camera, the V1100B-THM-TEMP.
Benzinga · 2d ago
48 Stocks Moving In Monday's Mid-Day Session
Gainers Cemtrex, Inc. (NASDAQ: CETX) shares jumped 198% to $2.8199.
Benzinga · 3d ago
MFGP, AAXN among premarket gainers
Seeking Alpha - Article · 3d ago
Proteostasis Therapeutics' PTI-129 a potential COVID-19 candidate
Seeking Alpha - Article · 3d ago
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
PR Newswire · 3d ago
Is Vertex Pharmaceuticals Stock a Buy?
MotleyFool.com · 05/24 18:04
Proteostasis Therapeutics: A Clinical Stage Company That's Worth The Risk
Seeking Alpha - Article · 05/23 05:08
Proteostasis Therapeutics EPS beats by $0.07
Proteostasis Therapeutics (NASDAQ:PTI): Q1 GAAP EPS of -$0.19 beats by $0.07. Cash, cash equivalents and short-term investments of $57.1M. Press Release 
seekingalpha · 05/16 01:13
Proteostasis Therapeutics (PTI) Reports Q1 Loss, Lags Revenue Estimates
Proteostasis (PTI) delivered earnings and revenue surprises of 17.39% and -100.00%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 05/15 21:25
Proteostasis Therapeutics Q1 EPS $(0.190) Up From $(0.280) YoY
Proteostasis Therapeutics (NASDAQ:PTI) reported quarterly losses of $(0.190) per share. This is a 32.14 percent increase over losses of $(0.280) per share from the same period last year.
Benzinga · 05/15 20:10
Proteostasis Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
Proteostasis Therapeutics, Inc. (Nasdaq: PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced financial results for the first quarter ended March
PR Newswire · 05/15 20:10
Proteostasis Therapeutics to Present at the 2020 RBC Capital Markets Global Healthcare Virtual Conference
Proteostasis Therapeutics, Inc. (NASDAQ:PTI), a clinical stage biopharmaceutical company dedicated to the discovery and development of groundbreaking therapies to treat cystic fibrosis (CF), today announced that Proteostasis management will present at the 2020
PR Newswire · 05/13 11:43
5 Top Stocks With Rising P/E to Bet On
Zacks · 05/12 14:02
Will Proteostasis Therapeutics (PTI) Report Negative Q1 Earnings? What You Should Know
Zacks · 05/06 17:30
Does Proteostasis Therapeutics, Inc. (NASDAQ:PTI) Have A Volatile Share Price?
Simply Wall St. · 04/24 14:29
Proteostasis Therapeutics Announces Completion of Scientific Advice Meeting with the Dutch Medicines Evaluation Board
PR Newswire · 04/13 12:00
RDS.A, NRZ among premarket gainers
Seeking Alpha - Article · 03/19 13:20
Proteostasis Therapeutics EPS beats by $0.06
seekingalpha · 03/11 01:41
Proteostasis Therapeutics Reports Fourth Quarter and Year-End 2019 Financial Results and Provides Corporate Update
PR Newswire · 03/10 21:36